• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

培养人类肠道干细胞用于炎症性肠病治疗中的再生应用。

Culturing human intestinal stem cells for regenerative applications in the treatment of inflammatory bowel disease.

作者信息

Holmberg Fredrik Eo, Seidelin Jakob B, Yin Xiaolei, Mead Benjamin E, Tong Zhixiang, Li Yuan, Karp Jeffrey M, Nielsen Ole H

机构信息

Department of Gastroenterology, Herlev Hospital, University of Copenhagen, Herlev, Denmark.

Division of BioEngineering in Medicine, Department of Medicine, Center for Regenerative Therapeutics, Brigham and Women's Hospital, Cambridge, MA, USA.

出版信息

EMBO Mol Med. 2017 May;9(5):558-570. doi: 10.15252/emmm.201607260.

DOI:10.15252/emmm.201607260
PMID:28283650
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5412884/
Abstract

Both the incidence and prevalence of inflammatory bowel disease (IBD) is increasing globally; in the industrialized world up to 0.5% of the population are affected and around 4.2 million individuals suffer from IBD in Europe and North America combined. Successful engraftment in experimental colitis models suggests that intestinal stem cell transplantation could constitute a novel treatment strategy to re-establish mucosal barrier function in patients with severe disease. Intestinal stem cells can be grown in organoid structures, though only a fraction of the cells contained are stem cells with regenerative capabilities. Hence, techniques to enrich stem cell populations are being pursued through the development of multiple two-dimensional and three-dimensional culture protocols, as well as co-culture techniques and multiple growth medium compositions. Moreover, research in support matrices allowing for efficient clinical application is in progress. culture is accomplished by modulating the signaling pathways fundamental for the stem cell niche with a suitable culture matrix to provide additional contact-dependent stimuli and structural support. The aim of this review was to discuss medium compositions and support matrices for optimal intestinal stem cell culture, as well as potential modifications to advance clinical use in IBD.

摘要

炎症性肠病(IBD)的发病率和患病率在全球范围内都在上升;在工业化国家,高达0.5%的人口受到影响,欧洲和北美合计约有420万人患有IBD。在实验性结肠炎模型中的成功植入表明,肠道干细胞移植可能构成一种新的治疗策略,用于在重症患者中重建黏膜屏障功能。肠道干细胞可以在类器官结构中生长,不过其中所含的细胞只有一小部分是具有再生能力的干细胞。因此,正在通过开发多种二维和三维培养方案、共培养技术以及多种生长培养基成分来探索富集干细胞群体的技术。此外,关于支持高效临床应用的支架材料的研究也在进行中。培养是通过用合适的培养基质调节对干细胞生态位至关重要的信号通路来实现的,以提供额外的接触依赖性刺激和结构支持。这篇综述的目的是讨论用于优化肠道干细胞培养的培养基成分和支持基质,以及为推进IBD临床应用而可能进行的改进。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bd41/5412884/9dddb33ccefc/EMMM-9-558-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bd41/5412884/b5f94f079c8e/EMMM-9-558-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bd41/5412884/6722a70d4574/EMMM-9-558-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bd41/5412884/b84d9e1a5590/EMMM-9-558-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bd41/5412884/9dddb33ccefc/EMMM-9-558-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bd41/5412884/b5f94f079c8e/EMMM-9-558-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bd41/5412884/6722a70d4574/EMMM-9-558-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bd41/5412884/b84d9e1a5590/EMMM-9-558-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bd41/5412884/9dddb33ccefc/EMMM-9-558-g004.jpg

相似文献

1
Culturing human intestinal stem cells for regenerative applications in the treatment of inflammatory bowel disease.培养人类肠道干细胞用于炎症性肠病治疗中的再生应用。
EMBO Mol Med. 2017 May;9(5):558-570. doi: 10.15252/emmm.201607260.
2
Organoid Medicine for Inflammatory Bowel Disease.用于炎症性肠病的类器官医学
Stem Cells. 2022 Mar 16;40(2):123-132. doi: 10.1093/stmcls/sxab020.
3
Converging biofabrication and organoid technologies: the next frontier in hepatic and intestinal tissue engineering?融合生物制造与类器官技术:肝脏和肠道组织工程的下一个前沿领域?
Biofabrication. 2017 Mar 6;9(1):013001. doi: 10.1088/1758-5090/aa6121.
4
Regulation of intestinal stem cell fate specification.肠道干细胞命运特化的调控。
Sci China Life Sci. 2015 Jun;58(6):570-8. doi: 10.1007/s11427-015-4859-7. Epub 2015 May 8.
5
Designer matrices for intestinal stem cell and organoid culture.肠道干细胞和类器官培养的设计基质。
Nature. 2016 Nov 24;539(7630):560-564. doi: 10.1038/nature20168. Epub 2016 Nov 16.
6
Expression of Wnt and Notch signaling pathways in inflammatory bowel disease treated with mesenchymal stem cell transplantation: evaluation in a rat model.间充质干细胞移植治疗炎症性肠病中Wnt和Notch信号通路的表达:大鼠模型评估
Stem Cell Res Ther. 2015 May 22;6(1):101. doi: 10.1186/s13287-015-0092-3.
7
Linking stem cell function and growth pattern of intestinal organoids.将干细胞功能与肠道类器官的生长模式相联系。
Dev Biol. 2018 Jan 15;433(2):254-261. doi: 10.1016/j.ydbio.2017.10.013. Epub 2017 Nov 30.
8
Intestinal stem cell transplantation.肠干细胞移植。
J Gastroenterol. 2017 Feb;52(2):151-157. doi: 10.1007/s00535-016-1288-8. Epub 2016 Nov 25.
9
EGF signaling activates proliferation and blocks apoptosis of mouse and human intestinal stem/progenitor cells in long-term monolayer cell culture.EGF 信号通路激活了小鼠和人肠道干细胞/祖细胞在长期单层细胞培养中的增殖并阻止其凋亡。
Lab Invest. 2010 Oct;90(10):1425-36. doi: 10.1038/labinvest.2010.150. Epub 2010 Aug 16.
10
Perspectives for Regenerative Medicine in the Treatment of Inflammatory Bowel Diseases.再生医学在炎症性肠病治疗中的前景
Digestion. 2015;92(2):73-7. doi: 10.1159/000438663. Epub 2015 Jul 30.

引用本文的文献

1
Circular RNAs in inflammatory bowel disease: a review of mechanisms, biomarkers and therapeutic potential.炎症性肠病中的环状RNA:机制、生物标志物及治疗潜力综述
Front Immunol. 2025 Apr 24;16:1540768. doi: 10.3389/fimmu.2025.1540768. eCollection 2025.
2
Chicken intestinal organoids reveal polarity-dependent replication dynamics and immune responses of low pathogenic avian influenza viruses.鸡肠道类器官揭示了低致病性禽流感病毒的极性依赖性复制动态和免疫反应。
Poult Sci. 2025 Apr;104(4):104921. doi: 10.1016/j.psj.2025.104921. Epub 2025 Feb 17.
3
Gastrointestinal tract organoids as novel tools in drug discovery.

本文引用的文献

1
Designer matrices for intestinal stem cell and organoid culture.肠道干细胞和类器官培养的设计基质。
Nature. 2016 Nov 24;539(7630):560-564. doi: 10.1038/nature20168. Epub 2016 Nov 16.
2
PGE is a direct and robust mediator of anion/fluid secretion by human intestinal epithelial cells.PGE 是人类肠道上皮细胞阴离子/液体分泌的直接而有力的介质。
Sci Rep. 2016 Nov 9;6:36795. doi: 10.1038/srep36795.
3
Alterations in the epithelial stem cell compartment could contribute to permanent changes in the mucosa of patients with ulcerative colitis.
胃肠道类器官作为药物发现的新工具。
Front Pharmacol. 2024 Aug 30;15:1463114. doi: 10.3389/fphar.2024.1463114. eCollection 2024.
4
Restore Intestinal Barrier Integrity: An Approach for Inflammatory Bowel Disease Therapy.恢复肠道屏障完整性:一种炎症性肠病的治疗方法。
J Inflamm Res. 2024 Aug 14;17:5389-5413. doi: 10.2147/JIR.S470520. eCollection 2024.
5
Gut microbiota modulating intestinal stem cell differentiation.肠道微生物群调节肠道干细胞分化。
World J Stem Cells. 2024 Jun 26;16(6):619-622. doi: 10.4252/wjsc.v16.i6.619.
6
Organoids as regenerative medicine for inflammatory bowel disease.类器官作为炎症性肠病的再生医学手段。
iScience. 2024 May 27;27(6):110118. doi: 10.1016/j.isci.2024.110118. eCollection 2024 Jun 21.
7
The Potential Role of Intestinal Stem Cells and Microbiota for the Treatment of Colorectal Cancer.肠干细胞和微生物群在结直肠癌治疗中的潜在作用。
Adv Exp Med Biol. 2024;1470:115-128. doi: 10.1007/5584_2024_803.
8
Mice with renal-specific alterations of stem cell-associated signaling develop symptoms of chronic kidney disease but surprisingly no tumors.具有肾特异性干细胞相关信号改变的小鼠会出现慢性肾脏病的症状,但令人惊讶的是没有肿瘤。
PLoS One. 2024 Mar 21;19(3):e0282938. doi: 10.1371/journal.pone.0282938. eCollection 2024.
9
CD73-Positive Cell Spheroid Transplantation Attenuates Colonic Atrophy.CD73阳性细胞球体移植减轻结肠萎缩。
Pharmaceutics. 2023 Mar 4;15(3):845. doi: 10.3390/pharmaceutics15030845.
10
Comprehensive protocols for culturing and molecular biological analysis of IBD patient-derived colon epithelial organoids.用于培养和分子生物学分析 IBD 患者来源结肠上皮类器官的综合方案。
Front Immunol. 2023 Feb 23;14:1097383. doi: 10.3389/fimmu.2023.1097383. eCollection 2023.
上皮干细胞区室的改变可能导致溃疡性结肠炎患者黏膜的永久性变化。
Gut. 2017 Dec;66(12):2069-2079. doi: 10.1136/gutjnl-2016-312609. Epub 2016 Nov 1.
4
Prostaglandin E2 promotes intestinal repair through an adaptive cellular response of the epithelium.前列腺素E2通过上皮细胞的适应性细胞反应促进肠道修复。
EMBO J. 2017 Jan 4;36(1):5-24. doi: 10.15252/embj.201694660. Epub 2016 Oct 24.
5
Single cell lineage tracing reveals a role for TgfβR2 in intestinal stem cell dynamics and differentiation.单细胞谱系追踪揭示了TgfβR2在肠道干细胞动态变化和分化中的作用。
Proc Natl Acad Sci U S A. 2016 Oct 25;113(43):12192-12197. doi: 10.1073/pnas.1611980113. Epub 2016 Oct 10.
6
Wnt pathway regulation of intestinal stem cells.肠道干细胞的Wnt信号通路调控
J Physiol. 2016 Sep 1;594(17):4837-47. doi: 10.1113/JP271754. Epub 2016 Jun 16.
7
Reg4+ deep crypt secretory cells function as epithelial niche for Lgr5+ stem cells in colon.Reg4+深部隐窝分泌细胞在结肠中作为Lgr5+干细胞的上皮微环境发挥作用。
Proc Natl Acad Sci U S A. 2016 Sep 13;113(37):E5399-407. doi: 10.1073/pnas.1607327113. Epub 2016 Aug 29.
8
Expanded allogeneic adipose-derived mesenchymal stem cells (Cx601) for complex perianal fistulas in Crohn's disease: a phase 3 randomised, double-blind controlled trial.异体扩增脂肪间充质干细胞(Cx601)治疗克罗恩病复杂性肛周瘘:一项 3 期随机、双盲对照临床试验。
Lancet. 2016 Sep 24;388(10051):1281-90. doi: 10.1016/S0140-6736(16)31203-X. Epub 2016 Jul 29.
9
TGF-β Signaling from Receptors to Smads.转化生长因子-β从受体到Smad蛋白的信号传导
Cold Spring Harb Perspect Biol. 2016 Sep 1;8(9):a022061. doi: 10.1101/cshperspect.a022061.
10
Bone Morphogenetic Proteins.骨形态发生蛋白
Cold Spring Harb Perspect Biol. 2016 Jun 1;8(6):a021899. doi: 10.1101/cshperspect.a021899.